ProLung, Inc. Recorded Big Gain
Thu, Feb 20, 2025 at 07:31 PM

ProLung, Inc. (LUNG:NASDAQ) soared at $8.78, representing a gain of 32.2%. On Thu, Feb 20, 2025, LUNG:NASDAQ touched a New 2-Week High of $8.78. The stock got featured on our News Catalysts scanner on Thu, Feb 20, 2025 at 02:58 AM in the 'MISCELLANEOUS' category. From Thu, Feb 06, 2025, the stock recorded 77.78% Up Days and 80.00% Green Days
About ProLung, Inc. (LUNG:NASDAQ)
ProLung Inc is a medical technology company which has developed lung cancer risk test called as ProLung Test to assess the risk of malignancy in lung nodules found in the chest by a Computed Tomography (CT) scan.
Top 10 Gainers:
- Mobile-health Network Solutions (MNDR:NASDAQ), 185.08%
- Xos Inc. (XOS:NASDAQ), 96.54%
- Volato Group Inc. Class A (SOAR:NYSEMKT), 49.25%
- Sharps Technology Inc. (STSS:NASDAQ), 44.77%
- Herbalife Nutrition Ltd. (HLF:NYSE), 42.7%
- Aureus Greenway Holdings Inc. (AGH:NASDAQ), 41.71%
- YSX Tech. Co. Ltd (YSXT:NASDAQ), 39.44%
- FibroGen, Inc. (FGEN:NASDAQ), 37.44%
- SRAX, Inc. (SRAX:NASDAQ), 33.33%
- ProLung, Inc. (LUNG:NASDAQ), 32.23%